기업 프로필 · Healthcare

IDEXX Laboratories Inc

IDXX · 미국
거래소
미국
국가 / 지역
USA
상장일
1991년 6월 21일
직원 수
11,000
웹사이트
www.idexx.com
현재가
$562.09
실시간 · 2026년 6월 18일
베일리 성장 점수
47/100
다소 약함
내재가치 · 3단계 구간 현재가 $562.09 실시간 · 낙관적 상단 위 · 미래 성장 과도 반영

종합 밸류에이션 구간 · 보수적 $240–$290 / 적정 $300–$380 / 낙관적 $400–$480. $562.09 기준, 낙관적 상단 위 · 미래 성장 과도 반영.

보고서 발행 시 $563(2026년 5월 22일)

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

시가총액US$430.77억
매출 (TTM)US$44.46억
EBITDAUS$15.46억
순이익률24.63%
ROE72.92%
PER (TTM)40.21
선행 PER37.04
PEG3.5
EPSUS$13.58
52주 범위US$506.91 – US$769.98
애널리스트 목표주가US$709.14
애널리스트 평가3.6 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.